» Articles » PMID: 36795544

Comorbidity and Severity in Childhood Apraxia of Speech: A Retrospective Chart Review

Overview
Date 2023 Feb 16
PMID 36795544
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: The purpose of this study was to investigate comorbidity prevalence and patterns in childhood apraxia of speech (CAS) and their relationship to severity.

Method: In this retroactive cross-sectional study, medical records for 375 children with CAS ( = 4;9 [years;months], = 2;9) were examined for comorbid conditions. The total number of comorbid conditions and the number of communication-related comorbidities were regressed on CAS severity as rated by speech-language pathologists during diagnosis. The relationship between CAS severity and the presence of four common comorbid conditions was also examined using ordinal or multinomial regressions.

Results: Overall, 83 children were classified with mild CAS; 35, with moderate CAS; and 257, with severe CAS. Only one child had no comorbidities. The average number of comorbid conditions was 8.4 ( = 3.4), and the average number of communication-related comorbidities was 5.6 ( = 2.2). Over 95% of children had comorbid expressive language impairment. Children with comorbid intellectual disability (78.1%), receptive language impairment (72.5%), and nonspeech apraxia (37.3%; including limb, nonspeech oromotor, and oculomotor apraxia) were significantly more likely to have severe CAS than children without these comorbidities. However, children with comorbid autism spectrum disorder (33.6%) were no more likely to have severe CAS than children without autism.

Conclusions: Comorbidity appears to be the rule, rather than the exception, for children with CAS. Comorbid intellectual disability, receptive language impairment, and nonspeech apraxia confer additional risk for more severe forms of CAS. Findings are limited by being from a convenience sample of participants but inform future models of comorbidity.

Supplemental Material: https://doi.org/10.23641/asha.22096622.

Citing Articles

Expanding the molecular landscape of childhood apraxia of speech: evidence from a single-center experience.

Formicola D, Podda I, Dirupo E, Andreucci E, Giglio S, Cipriani P Front Neurosci. 2024; 18:1396240.

PMID: 39381681 PMC: 11459770. DOI: 10.3389/fnins.2024.1396240.


Exploring vowel errors produced in nonword repetition in children with speech and language disorders.

Vuolo J, Gifford T Int J Lang Commun Disord. 2024; 59(6):2896-2910.

PMID: 39364675 PMC: 11567789. DOI: 10.1111/1460-6984.13120.


Concurrent Predictors of Supplementary Sign Use in School-Aged Children With Childhood Apraxia of Speech.

Chenausky K, Verdes A, Shield A Lang Speech Hear Serv Sch. 2022; 53(4):1149-1160.

PMID: 36191130 PMC: 9913131. DOI: 10.1044/2022_LSHSS-22-00017.

References
1.
Maas E, Butalla C, Farinella K . Feedback frequency in treatment for childhood apraxia of speech. Am J Speech Lang Pathol. 2012; 21(3):239-57. DOI: 10.1044/1058-0360(2012/11-0119). View

2.
Shriberg L, Paul R, Black L, van Santen J . The hypothesis of apraxia of speech in children with autism spectrum disorder. J Autism Dev Disord. 2010; 41(4):405-26. PMC: 3033475. DOI: 10.1007/s10803-010-1117-5. View

3.
Iuzzini-Seigel J, Hogan T, Green J . Speech Inconsistency in Children With Childhood Apraxia of Speech, Language Impairment, and Speech Delay: Depends on the Stimuli. J Speech Lang Hear Res. 2017; 60(5):1194-1210. DOI: 10.1044/2016_JSLHR-S-15-0184. View

4.
Fedorenko E, Morgan A, Murray E, Cardinaux A, Mei C, Tager-Flusberg H . A highly penetrant form of childhood apraxia of speech due to deletion of 16p11.2. Eur J Hum Genet. 2015; 24(2):302-6. PMC: 4717199. DOI: 10.1038/ejhg.2015.149. View

5.
Hildebrand M, Jackson V, Scerri T, Van Reyk O, Coleman M, Braden R . Severe childhood speech disorder: Gene discovery highlights transcriptional dysregulation. Neurology. 2020; 94(20):e2148-e2167. DOI: 10.1212/WNL.0000000000009441. View